9Stewart WF, Liberman JN, Sandier RS, et al. Epidemiology of constipation study in the United States: relation of clinical subtypes to sociodemographic features [ J ]. Am J Gastroenterol, 1999,94 (4) : 3530 - 3540.
10Schutze K, Brandstatter G, Judmaier G, et al. Double -blind study of the effect of cisapride on constipation and abdominal discomfort as components of the irritable bowel syndrome[ J]. Aliment Pharmacol Ther, 1997,11(2) :387 -394.
4[12]Bharucha AE, Camilleri M, Haydock S, et al. Effect of serotonin5-HT4 receptor antagonist SB-207266 on gastrointestinal motorand sensory function in human [J]. Gut, 2000, 47 (3): 667674.
5[13]Chiba T, Tbomforde GM, Kost LJ, et al. Motilide accelerated regional gastrointestinal transit in dog [J]. Aliment PharmacolTher ,2000,14(7):955-960.
6[14]Itoh Z. Motilin and cilinical application[J]. Peptide ,1997,18(4):593-608.
7[15]Jailwala J, Imperiale TF,Kroenke K. Pharmacologic treatment ofthe irritable bowel syndrome: a systematic review of randomized,controlled trials[J]. Ann Intern Med ,2000,133(2): 136 - 147.
8[16]Fioramonti J, Christen MO, Dupre I, et al. Effect of a selectivecalcium antagonist, pinaverium bromide, on sensitivity to rectaldistention in experimental inflammation in rats [J]. Gastroenterol, 1997, 112 (Suppl): A731.
